Two different types of botulinum toxins: Is there a difference in efficacy and longevity?
Abstract
[BACKGROUND] OnabotulinumtoxinA and incobotulinumtoxinA are two botulinum toxin A (BoNT-A) formulations commonly used in esthetic medicine. They are distinguished by whether complexing proteins are included with the active neurotoxin. While OnabotulinumtoxinA has complexing proteins, incobotulinumtoxinA does not; yet, it is unclear whether these differences affect their efficacy, longevity, and immunogenicity, especially in practices with high ambient temperatures.
[OBJECTIVES] To assess the efficacy and longevity of unreconstituted incobotulinumtoxinA with unreconstituted OnabotulinumtoxinA when stored and transported in a cold box to areas with high external ambient temperatures and to understand the implications of storing and transporting botulinum toxin to tropical areas with high ambient temperatures.
[METHODS] A prospective, randomized, and evaluator-blinded split-face trial was conducted in 30 patients with symmetrical, moderate-to-severe forehead lines. Following routine transportation and storage in thermocol cold boxes, OnabotulinumtoxinA or incobotulinumtoxinA was injected into corresponding sides of the frontalis to facilitate analysis within the same patient. Using a 4-point facial wrinkling grading scale and a clinical improvement scale, patients' outcomes were assessed over 24 weeks.
[RESULTS] Forehead lines reappeared in OnabotulinumtoxinA-treated patients after 8.3 weeks, compared to 10.1 weeks in incobotulinumtoxinA-treated patients. While side-vs-side improvements in forehead lines were observed for both toxins, after 8 weeks, improvements from were diminished relative to incobotulinumtoxinA, indicating that incobotulinumtoxinA was more effective at prolonged wrinkle relief.
[CONCLUSIONS] These results suggest that incobotulinumtoxinA is more stable at higher ambient temperatures, thus contributing to its better efficacy and longevity. IncobotulinumtoxinA is therefore more appropriate for practices in tropical climates.
[OBJECTIVES] To assess the efficacy and longevity of unreconstituted incobotulinumtoxinA with unreconstituted OnabotulinumtoxinA when stored and transported in a cold box to areas with high external ambient temperatures and to understand the implications of storing and transporting botulinum toxin to tropical areas with high ambient temperatures.
[METHODS] A prospective, randomized, and evaluator-blinded split-face trial was conducted in 30 patients with symmetrical, moderate-to-severe forehead lines. Following routine transportation and storage in thermocol cold boxes, OnabotulinumtoxinA or incobotulinumtoxinA was injected into corresponding sides of the frontalis to facilitate analysis within the same patient. Using a 4-point facial wrinkling grading scale and a clinical improvement scale, patients' outcomes were assessed over 24 weeks.
[RESULTS] Forehead lines reappeared in OnabotulinumtoxinA-treated patients after 8.3 weeks, compared to 10.1 weeks in incobotulinumtoxinA-treated patients. While side-vs-side improvements in forehead lines were observed for both toxins, after 8 weeks, improvements from were diminished relative to incobotulinumtoxinA, indicating that incobotulinumtoxinA was more effective at prolonged wrinkle relief.
[CONCLUSIONS] These results suggest that incobotulinumtoxinA is more stable at higher ambient temperatures, thus contributing to its better efficacy and longevity. IncobotulinumtoxinA is therefore more appropriate for practices in tropical climates.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 |
MeSH Terms
Adult; Botulinum Toxins, Type A; Drug Stability; Drug Storage; Female; Forehead; Hot Temperature; Humans; India; Injections, Intramuscular; Male; Middle Aged; Neuromuscular Agents; Prospective Studies; Skin Aging; Treatment Outcome; Tropical Climate; Young Adult
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.